Watch SRTA. Know when insiders buy.
One email the day a filing lands. Free.
SRTA
Strata Critical Medical, Inc.
5.19
−0.14 −2.63%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
32
FLAG · shorts 32
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $459.1MP/E 10.6DIV YIELD —FCF YIELD -10.55%REV TTM $256M +66.8%NET INCOME $40.2MNET CASH $16.3M52W 4.03 – 6.47SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $72.5M | +60.7% | 21.0% | −$5.4M | −$10.5M | — | -0.12 | $5.7M | $2.5M | $3.2M | Aug 4 |
| Q1 2026 · Mar 31 | $67.4M | +87.4% | 21.0% | −$3M | $2.2M | — | 0.03 | $3.9M | $5.2M | −$1.3M | May 6 |
| Q4 2025 · Dec 31derived | $66.8M | +83.5% | 17.5% | −$6.4M | −$8.8M | — | -0.12 | −$8.3M | $1.8M | −$10.2M | Mar 3 |
| Q3 2025 · Sep 30 | $49.3M | +36.7% | 23.6% | −$5.6M | $57.4M | — | 0.70 | −$37.3M | $2.9M | −$40.2M | Nov 10 |
| Q2 2025 · Jun 30 | $45.1M | −33.6% | 20.0% | −$4.6M | −$3.7M | — | -0.05 | −$3.1M | $2.2M | −$5.3M | Aug 4 |
| Q1 2025 · Mar 31 | $35.9M | −30.2% | 19.6% | −$5.7M | −$3.5M | — | -0.04 | −$246K | $2.6M | −$2.9M | May 6 |
| Q4 2024 · Dec 31derived | $36.4M | −23.4% | 13.8% | −$5.9M | −$9.8M | — | -0.12 | −$1.8M | $4.6M | −$6.3M | Mar 3 |
| Q3 2024 · Sep 30 | $36.1M | −49.5% | 20.8% | −$7.1M | −$2M | −776.1% | -0.03 | $6.4M | $9.3M | −$3M | Nov 10 |
| Q2 2024 · Jun 30 | $67.9M | — | 24.1% | −$12.1M | −$11.3M | — | -0.15 | $8.4M | $16.2M | −$7.7M | Aug 5 |
| Q1 2024 · Mar 31 | $51.5M | — | 19.7% | −$9.9M | −$4.2M | — | -0.06 | −$15.6M | $816K | −$16.4M | May 12 |
| Q4 2023 · Dec 31derived | $47.5M | — | 19.0% | −$35.6M | −$33.9M | — | -0.46 | −$9.3M | $24K | −$9.3M | Mar 13 |
| Q3 2023 · Sep 30 | $71.4M | — | 21.8% | −$7.4M | $289K | — | 0.00 | $2M | $695K | $1.3M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $197.1M | 20.9% | −$22.4M | $41.3M | 21.0% | 0.50 | −$48.9M | $9.6M | −$58.5M | $0 | — |
| FY2024 · to Dec 31 | $146.8M | 20.2% | −$22.5M | −$27.3M | -18.6% | -0.35 | −$2.5M | $30.9M | −$33.4M | $244K | — |
| FY2023 · to Dec 31 | $225.2M | 18.7% | −$68.1M | −$56.1M | -24.9% | -0.76 | −$32.3M | $2.1M | −$34.5M | $0 | — |
| FY2022 · to Dec 31 | $146.1M | 15.2% | −$53.5M | −$27.3M | -18.7% | -0.38 | −$37.1M | $730K | −$37.9M | — | — |
| FY2021 · to Sep 30 | $50.5M | 20.8% | −$24.1M | −$40.1M | -79.3% | -0.93 | −$15.6M | $297K | −$15.9M | — | — |
| FY2020 · to Dec 31 | — | — | −$678K | −$20.5M | — | -2.17 | −$794K | — | — | — | — |
Every number comes from Strata Critical Medical, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.